Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis

Overall, 51 papers were included for the final analyses (N = 51). These studies included 49,557 participants with CRC. The studies reported LS prevalence across 18 countries. 

Our results demonstrate that universal germline testing as a diagnostic tool yields the best estimates of clinically meaningful germline pathogenic variants. 

Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, with an estimated prevalence of 2% to 3% of CRC. A prevalence study is needed to provide accurate estimates of the true prevalence of LS.

https://www.gimjournal.org/article/S1098-3600(22)00030-2/fulltext#secsectitle0155

Leave a comment